Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells

This publication has 29 references indexed in Scilit:

• The spike protein of SARS-CoV — a target for vaccine and therapeutic development
  Nature Reviews Microbiology, 2009
• Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
  Published by Elsevier ,2006
• Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines
  Virology, 2006
• Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
  Proceedings of the National Academy of Sciences, 2005
• Receptor-binding domain of SARS-Cov spike protein: Soluble expression inE.coli, purification and functional characterization
  World Journal of Gastroenterology, 2005
• Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
  Published by Elsevier ,2004
• High-level expression of a codon optimized recombinant dust mite allergen, Blo t 5, in Chinese hamster ovary cells
  Biochemical and Biophysical Research Communications, 2004
• Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells
  Biochemical Journal, 2003
• Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003
  The Lancet, 2003
• Development of a Chinese Hamster Ovary Cell Line for Recombinant Adenovirus‐Mediated Gene Expression
  Biotechnology Progress, 2003